ArticleAlzheimer's & dementia (New York, N. Y.)2015

A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia.

Laura M Gault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.